aluates Reports

$ 0.0

Automative

Circulating Tumor Cell (CTC) Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: September 2024

Report Code: QYRE-Auto-9P12397

Global Circulating Tumor Cell CTC Diagnostics Industry Research Report Growth Trends and Competitive Analysis 2022 2028

BUY CHAPTERS

Circulating Tumor Cell (CTC) Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-9P12397

Report

September 2024

Pages:132

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

ApoCell, Inc. (US)

Biocep Ltd. (Israel)

Biocept, Inc. (US)

Biofluidica MicrotechnologiesLLc(US)

Celltraffix Inc. (US)

ClearbridgeBiomedics(Singapore)

Creatv Microtech, Inc. (US)

CynvenioBiosystems, Inc.(US)

EpicBiosciencesInc.(US)

FluxionBiosciences, Inc.(US)

Ikonisys, Inc. (US)

IVDiagnostics, Inc. (US)

JanssenDiagnosticsLLc(US)

QIAGEnHannoverGmbH (Germany)

RARECELLsSAs(Italy)

ScreenCell (France)

STEMCELlTechnologies, Inc.(Canada)

Circulating Tumor Cell (CTC) Diagnostics - Market Size

The global market for Circulating Tumor Cell (CTC) Diagnostics was estimated to be worth US$ 7394.8 million in 2023 and is forecast to a readjusted size of US$ 20170 million by 2030 with a CAGR of 15.1% during the forecast period 2024-2030

Circulating Tumor Cell (CTC) Diagnostics - Market

Circulatingtumorcells(CTCs)arecellsthathaveshed intothevasculatureorlymphaticsfrom a primarytumorand arecarried around thebodyintheblood circulation.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Circulating Tumor Cell (CTC) Diagnostics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Circulating Tumor Cell (CTC) Diagnostics by region & country, by Type, and by Application.

The Circulating Tumor Cell (CTC) Diagnostics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Circulating Tumor Cell (CTC) Diagnostics.

Market Segmentation

Scope of Circulating Tumor Cell (CTC) Diagnostics - Market Report

Report Metric	Details
Report Name	Circulating Tumor Cell (CTC) Diagnostics - Market
Forecasted market size in 2030	US$ 20170 million
CAGR	15.1%
Forecasted years	2024 - 2030
Segment by Type:	CTC Enrichment CTC Detection
Segment by Application	Hospitals and clinics Pharmaceuticals and biotechnology companies Academic research institutes CROs
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	ApoCell, Inc.(US), Biocep Ltd. (Israel), Biocept, Inc.(US), Biofluidica MicrotechnologiesLLc(US), Celltraffix Inc.(US), ClearbridgeBiomedics(Singapore), Creatv Microtech, Inc.(US), CynvenioBiosystems, Inc.(US), EpicBiosciencesInc.(US), FluxionBiosciences, Inc.(US), Ikonisys, Inc.(US), IVDiagnostics, Inc.(US), JanssenDiagnosticsLLc(US), QIAGEnHannoverGmbH (Germany), RARECELLsSAs(Italy), ScreenCell(France), STEMCELlTechnologies, Inc.(Canada)
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Circulating Tumor Cell (CTC) Diagnostics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Circulating Tumor Cell (CTC) Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Circulating Tumor Cell (CTC) Diagnostics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Circulating Tumor Cell (CTC) Diagnostics - Market size in 2030?

Ans: The Circulating Tumor Cell (CTC) Diagnostics - Market size in 2030 will be US$ 20170 million.

Who are the main players in the Circulating Tumor Cell (CTC) Diagnostics - Market report?

Ans: The main players in the Circulating Tumor Cell (CTC) Diagnostics - Market are ApoCell, Inc.(US), Biocep Ltd. (Israel), Biocept, Inc.(US), Biofluidica MicrotechnologiesLLc(US), Celltraffix Inc.(US), ClearbridgeBiomedics(Singapore), Creatv Microtech, Inc.(US), CynvenioBiosystems, Inc.(US), EpicBiosciencesInc.(US), FluxionBiosciences, Inc.(US), Ikonisys, Inc.(US), IVDiagnostics, Inc.(US), JanssenDiagnosticsLLc(US), QIAGEnHannoverGmbH (Germany), RARECELLsSAs(Italy), ScreenCell(France), STEMCELlTechnologies, Inc.(Canada)

What are the Application segmentation covered in the Circulating Tumor Cell (CTC) Diagnostics - Market report?

Ans: The Applications covered in the Circulating Tumor Cell (CTC) Diagnostics - Market report are Hospitals and clinics, Pharmaceuticals and biotechnology companies, Academic research institutes, CROs

What are the Type segmentation covered in the Circulating Tumor Cell (CTC) Diagnostics - Market report?

Ans: The Types covered in the Circulating Tumor Cell (CTC) Diagnostics - Market report are CTC Enrichment, CTC Detection

Recommended Reports

Cancer Diagnostics

Cancer Therapeutics

Cancer Cell Therapies

1 Market Overview

1.1 Circulating Tumor Cell (CTC) Diagnostics Product Introduction

1.2 Global Circulating Tumor Cell (CTC) Diagnostics Market Size Forecast

1.3 Circulating Tumor Cell (CTC) Diagnostics Market Trends & Drivers

1.3.1 Circulating Tumor Cell (CTC) Diagnostics Industry Trends

1.3.2 Circulating Tumor Cell (CTC) Diagnostics Market Drivers & Opportunity

1.3.3 Circulating Tumor Cell (CTC) Diagnostics Market Challenges

1.3.4 Circulating Tumor Cell (CTC) Diagnostics Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Circulating Tumor Cell (CTC) Diagnostics Players Revenue Ranking (2023)

2.2 Global Circulating Tumor Cell (CTC) Diagnostics Revenue by Company (2019-2024)

2.3 Key Companies Circulating Tumor Cell (CTC) Diagnostics Manufacturing Base Distribution and Headquarters

2.4 Key Companies Circulating Tumor Cell (CTC) Diagnostics Product Offered

2.5 Key Companies Time to Begin Mass Production of Circulating Tumor Cell (CTC) Diagnostics

2.6 Circulating Tumor Cell (CTC) Diagnostics Market Competitive Analysis

2.6.1 Circulating Tumor Cell (CTC) Diagnostics Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Circulating Tumor Cell (CTC) Diagnostics Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Tumor Cell (CTC) Diagnostics as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 CTC Enrichment

3.1.2 CTC Detection

3.2 Global Circulating Tumor Cell (CTC) Diagnostics Sales Value by Type

3.2.1 Global Circulating Tumor Cell (CTC) Diagnostics Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Circulating Tumor Cell (CTC) Diagnostics Sales Value, by Type (2019-2030)

3.2.3 Global Circulating Tumor Cell (CTC) Diagnostics Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospitals and clinics

4.1.2 Pharmaceuticals and biotechnology companies

4.1.3 Academic research institutes

4.1.4 CROs

4.2 Global Circulating Tumor Cell (CTC) Diagnostics Sales Value by Application

4.2.1 Global Circulating Tumor Cell (CTC) Diagnostics Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Circulating Tumor Cell (CTC) Diagnostics Sales Value, by Application (2019-2030)

4.2.3 Global Circulating Tumor Cell (CTC) Diagnostics Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Circulating Tumor Cell (CTC) Diagnostics Sales Value by Region

5.1.1 Global Circulating Tumor Cell (CTC) Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Circulating Tumor Cell (CTC) Diagnostics Sales Value by Region (2019-2024)

5.1.3 Global Circulating Tumor Cell (CTC) Diagnostics Sales Value by Region (2025-2030)

5.1.4 Global Circulating Tumor Cell (CTC) Diagnostics Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Circulating Tumor Cell (CTC) Diagnostics Sales Value, 2019-2030

5.2.2 North America Circulating Tumor Cell (CTC) Diagnostics Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Circulating Tumor Cell (CTC) Diagnostics Sales Value, 2019-2030

5.3.2 Europe Circulating Tumor Cell (CTC) Diagnostics Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Sales Value, 2019-2030

5.4.2 Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Circulating Tumor Cell (CTC) Diagnostics Sales Value, 2019-2030

5.5.2 South America Circulating Tumor Cell (CTC) Diagnostics Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Sales Value, 2019-2030

5.6.2 Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Circulating Tumor Cell (CTC) Diagnostics Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Circulating Tumor Cell (CTC) Diagnostics Sales Value

6.3 United States

6.3.1 United States Circulating Tumor Cell (CTC) Diagnostics Sales Value, 2019-2030

6.3.2 United States Circulating Tumor Cell (CTC) Diagnostics Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Circulating Tumor Cell (CTC) Diagnostics Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Circulating Tumor Cell (CTC) Diagnostics Sales Value, 2019-2030

6.4.2 Europe Circulating Tumor Cell (CTC) Diagnostics Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Circulating Tumor Cell (CTC) Diagnostics Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Circulating Tumor Cell (CTC) Diagnostics Sales Value, 2019-2030

6.5.2 China Circulating Tumor Cell (CTC) Diagnostics Sales Value by Type (%), 2023 VS 2030

6.5.3 China Circulating Tumor Cell (CTC) Diagnostics Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Circulating Tumor Cell (CTC) Diagnostics Sales Value, 2019-2030

6.6.2 Japan Circulating Tumor Cell (CTC) Diagnostics Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Circulating Tumor Cell (CTC) Diagnostics Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Circulating Tumor Cell (CTC) Diagnostics Sales Value, 2019-2030

6.7.2 South Korea Circulating Tumor Cell (CTC) Diagnostics Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Circulating Tumor Cell (CTC) Diagnostics Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Circulating Tumor Cell (CTC) Diagnostics Sales Value, 2019-2030

6.8.2 Southeast Asia Circulating Tumor Cell (CTC) Diagnostics Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Circulating Tumor Cell (CTC) Diagnostics Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Circulating Tumor Cell (CTC) Diagnostics Sales Value, 2019-2030

6.9.2 India Circulating Tumor Cell (CTC) Diagnostics Sales Value by Type (%), 2023 VS 2030

6.9.3 India Circulating Tumor Cell (CTC) Diagnostics Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 ApoCell, Inc.(US)

7.1.1 ApoCell, Inc.(US) Profile

7.1.2 ApoCell, Inc.(US) Main Business

7.1.3 ApoCell, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Products, Services and Solutions

7.1.4 ApoCell, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue (US$ Million) & (2019-2024)

7.1.5 ApoCell, Inc.(US) Recent Developments

7.2 Biocep Ltd. (Israel)

7.2.1 Biocep Ltd. (Israel) Profile

7.2.2 Biocep Ltd. (Israel) Main Business

7.2.3 Biocep Ltd. (Israel) Circulating Tumor Cell (CTC) Diagnostics Products, Services and Solutions

7.2.4 Biocep Ltd. (Israel) Circulating Tumor Cell (CTC) Diagnostics Revenue (US$ Million) & (2019-2024)

7.2.5 Biocep Ltd. (Israel) Recent Developments

7.3 Biocept, Inc.(US)

7.3.1 Biocept, Inc.(US) Profile

7.3.2 Biocept, Inc.(US) Main Business

7.3.3 Biocept, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Products, Services and Solutions

7.3.4 Biocept, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue (US$ Million) & (2019-2024)

7.3.5 Biofluidica MicrotechnologiesLLc(US) Recent Developments

7.4 Biofluidica MicrotechnologiesLLc(US)

7.4.1 Biofluidica MicrotechnologiesLLc(US) Profile

7.4.2 Biofluidica MicrotechnologiesLLc(US) Main Business

7.4.3 Biofluidica MicrotechnologiesLLc(US) Circulating Tumor Cell (CTC) Diagnostics Products, Services and Solutions

7.4.4 Biofluidica MicrotechnologiesLLc(US) Circulating Tumor Cell (CTC) Diagnostics Revenue (US$ Million) & (2019-2024)

7.4.5 Biofluidica MicrotechnologiesLLc(US) Recent Developments

7.5 Celltraffix Inc.(US)

7.5.1 Celltraffix Inc.(US) Profile

7.5.2 Celltraffix Inc.(US) Main Business

7.5.3 Celltraffix Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Products, Services and Solutions

7.5.4 Celltraffix Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue (US$ Million) & (2019-2024)

7.5.5 Celltraffix Inc.(US) Recent Developments

7.6 ClearbridgeBiomedics(Singapore)

7.6.1 ClearbridgeBiomedics(Singapore) Profile

7.6.2 ClearbridgeBiomedics(Singapore) Main Business

7.6.3 ClearbridgeBiomedics(Singapore) Circulating Tumor Cell (CTC) Diagnostics Products, Services and Solutions

7.6.4 ClearbridgeBiomedics(Singapore) Circulating Tumor Cell (CTC) Diagnostics Revenue (US$ Million) & (2019-2024)

7.6.5 ClearbridgeBiomedics(Singapore) Recent Developments

7.7 Creatv Microtech, Inc.(US)

7.7.1 Creatv Microtech, Inc.(US) Profile

7.7.2 Creatv Microtech, Inc.(US) Main Business

7.7.3 Creatv Microtech, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Products, Services and Solutions

7.7.4 Creatv Microtech, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue (US$ Million) & (2019-2024)

7.7.5 Creatv Microtech, Inc.(US) Recent Developments

7.8 CynvenioBiosystems, Inc.(US)

7.8.1 CynvenioBiosystems, Inc.(US) Profile

7.8.2 CynvenioBiosystems, Inc.(US) Main Business

7.8.3 CynvenioBiosystems, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Products, Services and Solutions

7.8.4 CynvenioBiosystems, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue (US$ Million) & (2019-2024)

7.8.5 CynvenioBiosystems, Inc.(US) Recent Developments

7.9 EpicBiosciencesInc.(US)

7.9.1 EpicBiosciencesInc.(US) Profile

7.9.2 EpicBiosciencesInc.(US) Main Business

7.9.3 EpicBiosciencesInc.(US) Circulating Tumor Cell (CTC) Diagnostics Products, Services and Solutions

7.9.4 EpicBiosciencesInc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue (US$ Million) & (2019-2024)

7.9.5 EpicBiosciencesInc.(US) Recent Developments

7.10 FluxionBiosciences, Inc.(US)

7.10.1 FluxionBiosciences, Inc.(US) Profile

7.10.2 FluxionBiosciences, Inc.(US) Main Business

7.10.3 FluxionBiosciences, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Products, Services and Solutions

7.10.4 FluxionBiosciences, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue (US$ Million) & (2019-2024)

7.10.5 FluxionBiosciences, Inc.(US) Recent Developments

7.11 Ikonisys, Inc.(US)

7.11.1 Ikonisys, Inc.(US) Profile

7.11.2 Ikonisys, Inc.(US) Main Business

7.11.3 Ikonisys, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Products, Services and Solutions

7.11.4 Ikonisys, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue (US$ Million) & (2019-2024)

7.11.5 Ikonisys, Inc.(US) Recent Developments

7.12 IVDiagnostics, Inc.(US)

7.12.1 IVDiagnostics, Inc.(US) Profile

7.12.2 IVDiagnostics, Inc.(US) Main Business

7.12.3 IVDiagnostics, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Products, Services and Solutions

7.12.4 IVDiagnostics, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Revenue (US$ Million) & (2019-2024)

7.12.5 IVDiagnostics, Inc.(US) Recent Developments

7.13 JanssenDiagnosticsLLc(US)

7.13.1 JanssenDiagnosticsLLc(US) Profile

7.13.2 JanssenDiagnosticsLLc(US) Main Business

7.13.3 JanssenDiagnosticsLLc(US) Circulating Tumor Cell (CTC) Diagnostics Products, Services and Solutions

7.13.4 JanssenDiagnosticsLLc(US) Circulating Tumor Cell (CTC) Diagnostics Revenue (US$ Million) & (2019-2024)

7.13.5 JanssenDiagnosticsLLc(US) Recent Developments

7.14 QIAGEnHannoverGmbH (Germany)

7.14.1 QIAGEnHannoverGmbH (Germany) Profile

7.14.2 QIAGEnHannoverGmbH (Germany) Main Business

7.14.3 QIAGEnHannoverGmbH (Germany) Circulating Tumor Cell (CTC) Diagnostics Products, Services and Solutions

7.14.4 QIAGEnHannoverGmbH (Germany) Circulating Tumor Cell (CTC) Diagnostics Revenue (US$ Million) & (2019-2024)

7.14.5 QIAGEnHannoverGmbH (Germany) Recent Developments

7.15 RARECELLsSAs(Italy)

7.15.1 RARECELLsSAs(Italy) Profile

7.15.2 RARECELLsSAs(Italy) Main Business

7.15.3 RARECELLsSAs(Italy) Circulating Tumor Cell (CTC) Diagnostics Products, Services and Solutions

7.15.4 RARECELLsSAs(Italy) Circulating Tumor Cell (CTC) Diagnostics Revenue (US$ Million) & (2019-2024)

7.15.5 RARECELLsSAs(Italy) Recent Developments

7.16 ScreenCell(France)

7.16.1 ScreenCell(France) Profile

7.16.2 ScreenCell(France) Main Business

7.16.3 ScreenCell(France) Circulating Tumor Cell (CTC) Diagnostics Products, Services and Solutions

7.16.4 ScreenCell(France) Circulating Tumor Cell (CTC) Diagnostics Revenue (US$ Million) & (2019-2024)

7.16.5 ScreenCell(France) Recent Developments

7.17 STEMCELlTechnologies, Inc.(Canada)

7.17.1 STEMCELlTechnologies, Inc.(Canada) Profile

7.17.2 STEMCELlTechnologies, Inc.(Canada) Main Business

7.17.3 STEMCELlTechnologies, Inc.(Canada) Circulating Tumor Cell (CTC) Diagnostics Products, Services and Solutions

7.17.4 STEMCELlTechnologies, Inc.(Canada) Circulating Tumor Cell (CTC) Diagnostics Revenue (US$ Million) & (2019-2024)

7.17.5 STEMCELlTechnologies, Inc.(Canada) Recent Developments

8 Industry Chain Analysis

8.1 Circulating Tumor Cell (CTC) Diagnostics Industrial Chain

8.2 Circulating Tumor Cell (CTC) Diagnostics Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Circulating Tumor Cell (CTC) Diagnostics Sales Model

8.5.2 Sales Channel

8.5.3 Circulating Tumor Cell (CTC) Diagnostics Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

ApoCell, Inc. (US)

Biocep Ltd. (Israel)

Biocept, Inc. (US)

Biofluidica MicrotechnologiesLLc(US)

Celltraffix Inc. (US)

ClearbridgeBiomedics(Singapore)

Creatv Microtech, Inc. (US)

CynvenioBiosystems, Inc.(US)

EpicBiosciencesInc.(US)

FluxionBiosciences, Inc.(US)

Ikonisys, Inc. (US)

IVDiagnostics, Inc. (US)

JanssenDiagnosticsLLc(US)

QIAGEnHannoverGmbH (Germany)

RARECELLsSAs(Italy)

ScreenCell (France)

STEMCELlTechnologies, Inc.(Canada)

List of Tables

Table 1. Circulating Tumor Cell (CTC) Diagnostics Market Trends

Table 2. Circulating Tumor Cell (CTC) Diagnostics Market Drivers & Opportunity

Table 3. Circulating Tumor Cell (CTC) Diagnostics Market Challenges

Table 4. Circulating Tumor Cell (CTC) Diagnostics Market Restraints

Table 5. Global Circulating Tumor Cell (CTC) Diagnostics Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Circulating Tumor Cell (CTC) Diagnostics Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Circulating Tumor Cell (CTC) Diagnostics Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Circulating Tumor Cell (CTC) Diagnostics Product Type

Table 9. Key Companies Time to Begin Mass Production of Circulating Tumor Cell (CTC) Diagnostics

Table 10. Global Circulating Tumor Cell (CTC) Diagnostics Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Tumor Cell (CTC) Diagnostics as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Circulating Tumor Cell (CTC) Diagnostics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Circulating Tumor Cell (CTC) Diagnostics Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Circulating Tumor Cell (CTC) Diagnostics Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Circulating Tumor Cell (CTC) Diagnostics Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Circulating Tumor Cell (CTC) Diagnostics Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Circulating Tumor Cell (CTC) Diagnostics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Circulating Tumor Cell (CTC) Diagnostics Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Circulating Tumor Cell (CTC) Diagnostics Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Circulating Tumor Cell (CTC) Diagnostics Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Circulating Tumor Cell (CTC) Diagnostics Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Circulating Tumor Cell (CTC) Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Circulating Tumor Cell (CTC) Diagnostics Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Circulating Tumor Cell (CTC) Diagnostics Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Circulating Tumor Cell (CTC) Diagnostics Sales Value by Region (2019-2024) & (%)

Table 27. Global Circulating Tumor Cell (CTC) Diagnostics Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Circulating Tumor Cell (CTC) Diagnostics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Circulating Tumor Cell (CTC) Diagnostics Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Circulating Tumor Cell (CTC) Diagnostics Sales Value, (2025-2030) & (US$ Million)

Table 31. ApoCell, Inc.(US) Basic Information List

Table 32. ApoCell, Inc.(US) Description and Business Overview

Table 33. ApoCell, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Products, Services and Solutions

Table 34. Revenue (US$ Million) in Circulating Tumor Cell (CTC) Diagnostics Business of ApoCell, Inc.(US) (2019-2024)

Table 35. ApoCell, Inc.(US) Recent Developments

Table 36. Biocep Ltd. (Israel) Basic Information List

Table 37. Biocep Ltd. (Israel) Description and Business Overview

Table 38. Biocep Ltd. (Israel) Circulating Tumor Cell (CTC) Diagnostics Products, Services and Solutions

Table 39. Revenue (US$ Million) in Circulating Tumor Cell (CTC) Diagnostics Business of Biocep Ltd. (Israel) (2019-2024)

Table 40. Biocep Ltd. (Israel) Recent Developments

Table 41. Biocept, Inc.(US) Basic Information List

Table 42. Biocept, Inc.(US) Description and Business Overview

Table 43. Biocept, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Products, Services and Solutions

Table 44. Revenue (US$ Million) in Circulating Tumor Cell (CTC) Diagnostics Business of Biocept, Inc.(US) (2019-2024)

Table 45. Biocept, Inc.(US) Recent Developments

Table 46. Biofluidica MicrotechnologiesLLc(US) Basic Information List

Table 47. Biofluidica MicrotechnologiesLLc(US) Description and Business Overview

Table 48. Biofluidica MicrotechnologiesLLc(US) Circulating Tumor Cell (CTC) Diagnostics Products, Services and Solutions

Table 49. Revenue (US$ Million) in Circulating Tumor Cell (CTC) Diagnostics Business of Biofluidica MicrotechnologiesLLc(US) (2019-2024)

Table 50. Biofluidica MicrotechnologiesLLc(US) Recent Developments

Table 51. Celltraffix Inc.(US) Basic Information List

Table 52. Celltraffix Inc.(US) Description and Business Overview

Table 53. Celltraffix Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Products, Services and Solutions

Table 54. Revenue (US$ Million) in Circulating Tumor Cell (CTC) Diagnostics Business of Celltraffix Inc.(US) (2019-2024)

Table 55. Celltraffix Inc.(US) Recent Developments

Table 56. ClearbridgeBiomedics(Singapore) Basic Information List

Table 57. ClearbridgeBiomedics(Singapore) Description and Business Overview

Table 58. ClearbridgeBiomedics(Singapore) Circulating Tumor Cell (CTC) Diagnostics Products, Services and Solutions

Table 59. Revenue (US$ Million) in Circulating Tumor Cell (CTC) Diagnostics Business of ClearbridgeBiomedics(Singapore) (2019-2024)

Table 60. ClearbridgeBiomedics(Singapore) Recent Developments

Table 61. Creatv Microtech, Inc.(US) Basic Information List

Table 62. Creatv Microtech, Inc.(US) Description and Business Overview

Table 63. Creatv Microtech, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Products, Services and Solutions

Table 64. Revenue (US$ Million) in Circulating Tumor Cell (CTC) Diagnostics Business of Creatv Microtech, Inc.(US) (2019-2024)

Table 65. Creatv Microtech, Inc.(US) Recent Developments

Table 66. CynvenioBiosystems, Inc.(US) Basic Information List

Table 67. CynvenioBiosystems, Inc.(US) Description and Business Overview

Table 68. CynvenioBiosystems, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Products, Services and Solutions

Table 69. Revenue (US$ Million) in Circulating Tumor Cell (CTC) Diagnostics Business of CynvenioBiosystems, Inc.(US) (2019-2024)

Table 70. CynvenioBiosystems, Inc.(US) Recent Developments

Table 71. EpicBiosciencesInc.(US) Basic Information List

Table 72. EpicBiosciencesInc.(US) Description and Business Overview

Table 73. EpicBiosciencesInc.(US) Circulating Tumor Cell (CTC) Diagnostics Products, Services and Solutions

Table 74. Revenue (US$ Million) in Circulating Tumor Cell (CTC) Diagnostics Business of EpicBiosciencesInc.(US) (2019-2024)

Table 75. EpicBiosciencesInc.(US) Recent Developments

Table 76. FluxionBiosciences, Inc.(US) Basic Information List

Table 77. FluxionBiosciences, Inc.(US) Description and Business Overview

Table 78. FluxionBiosciences, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Products, Services and Solutions

Table 79. Revenue (US$ Million) in Circulating Tumor Cell (CTC) Diagnostics Business of FluxionBiosciences, Inc.(US) (2019-2024)

Table 80. FluxionBiosciences, Inc.(US) Recent Developments

Table 81. Ikonisys, Inc.(US) Basic Information List

Table 82. Ikonisys, Inc.(US) Description and Business Overview

Table 83. Ikonisys, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Products, Services and Solutions

Table 84. Revenue (US$ Million) in Circulating Tumor Cell (CTC) Diagnostics Business of Ikonisys, Inc.(US) (2019-2024)

Table 85. Ikonisys, Inc.(US) Recent Developments

Table 86. IVDiagnostics, Inc.(US) Basic Information List

Table 87. IVDiagnostics, Inc.(US) Description and Business Overview

Table 88. IVDiagnostics, Inc.(US) Circulating Tumor Cell (CTC) Diagnostics Products, Services and Solutions

Table 89. Revenue (US$ Million) in Circulating Tumor Cell (CTC) Diagnostics Business of IVDiagnostics, Inc.(US) (2019-2024)

Table 90. IVDiagnostics, Inc.(US) Recent Developments

Table 91. JanssenDiagnosticsLLc(US) Basic Information List

Table 92. JanssenDiagnosticsLLc(US) Description and Business Overview

Table 93. JanssenDiagnosticsLLc(US) Circulating Tumor Cell (CTC) Diagnostics Products, Services and Solutions

Table 94. Revenue (US$ Million) in Circulating Tumor Cell (CTC) Diagnostics Business of JanssenDiagnosticsLLc(US) (2019-2024)

Table 95. JanssenDiagnosticsLLc(US) Recent Developments

Table 96. QIAGEnHannoverGmbH (Germany) Basic Information List

Table 97. QIAGEnHannoverGmbH (Germany) Description and Business Overview

Table 98. QIAGEnHannoverGmbH (Germany) Circulating Tumor Cell (CTC) Diagnostics Products, Services and Solutions

Table 99. Revenue (US$ Million) in Circulating Tumor Cell (CTC) Diagnostics Business of QIAGEnHannoverGmbH (Germany) (2019-2024)

Table 100. QIAGEnHannoverGmbH (Germany) Recent Developments

Table 101. RARECELLsSAs(Italy) Basic Information List

Table 102. RARECELLsSAs(Italy) Description and Business Overview

Table 103. RARECELLsSAs(Italy) Circulating Tumor Cell (CTC) Diagnostics Products, Services and Solutions

Table 104. Revenue (US$ Million) in Circulating Tumor Cell (CTC) Diagnostics Business of RARECELLsSAs(Italy) (2019-2024)

Table 105. RARECELLsSAs(Italy) Recent Developments

Table 106. ScreenCell(France) Basic Information List

Table 107. ScreenCell(France) Description and Business Overview

Table 108. ScreenCell(France) Circulating Tumor Cell (CTC) Diagnostics Products, Services and Solutions

Table 109. Revenue (US$ Million) in Circulating Tumor Cell (CTC) Diagnostics Business of ScreenCell(France) (2019-2024)

Table 110. ScreenCell(France) Recent Developments

Table 111. STEMCELlTechnologies, Inc.(Canada) Basic Information List

Table 112. STEMCELlTechnologies, Inc.(Canada) Description and Business Overview

Table 113. STEMCELlTechnologies, Inc.(Canada) Circulating Tumor Cell (CTC) Diagnostics Products, Services and Solutions

Table 114. Revenue (US$ Million) in Circulating Tumor Cell (CTC) Diagnostics Business of STEMCELlTechnologies, Inc.(Canada) (2019-2024)

Table 115. STEMCELlTechnologies, Inc.(Canada) Recent Developments

Table 116. Key Raw Materials Lists

Table 117. Raw Materials Key Suppliers Lists

Table 118. Circulating Tumor Cell (CTC) Diagnostics Downstream Customers

Table 119. Circulating Tumor Cell (CTC) Diagnostics Distributors List

Table 120. Research Programs/Design for This Report

Table 121. Key Data Information from Secondary Sources

Table 122. Key Data Information from Primary Sources

Table 123. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Circulating Tumor Cell (CTC) Diagnostics Product Picture

Figure 2. Global Circulating Tumor Cell (CTC) Diagnostics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Circulating Tumor Cell (CTC) Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 4. Circulating Tumor Cell (CTC) Diagnostics Report Years Considered

Figure 5. Global Circulating Tumor Cell (CTC) Diagnostics Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Circulating Tumor Cell (CTC) Diagnostics Revenue in 2023

Figure 7. Circulating Tumor Cell (CTC) Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. CTC Enrichment Picture

Figure 9. CTC Detection Picture

Figure 10. Global Circulating Tumor Cell (CTC) Diagnostics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 11. Global Circulating Tumor Cell (CTC) Diagnostics Sales Value Market Share by Type, 2023 & 2030

Figure 12. Product Picture of Hospitals and clinics

Figure 13. Product Picture of Pharmaceuticals and biotechnology companies

Figure 14. Product Picture of Academic research institutes

Figure 15. Product Picture of CROs

Figure 16. Global Circulating Tumor Cell (CTC) Diagnostics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 17. Global Circulating Tumor Cell (CTC) Diagnostics Sales Value Market Share by Application, 2023 & 2030

Figure 18. North America Circulating Tumor Cell (CTC) Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 19. North America Circulating Tumor Cell (CTC) Diagnostics Sales Value by Country (%), 2023 VS 2030

Figure 20. Europe Circulating Tumor Cell (CTC) Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 21. Europe Circulating Tumor Cell (CTC) Diagnostics Sales Value by Country (%), 2023 VS 2030

Figure 22. Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 23. Asia Pacific Circulating Tumor Cell (CTC) Diagnostics Sales Value by Country (%), 2023 VS 2030

Figure 24. South America Circulating Tumor Cell (CTC) Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 25. South America Circulating Tumor Cell (CTC) Diagnostics Sales Value by Country (%), 2023 VS 2030

Figure 26. Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Sales Value (2019-2030) & (US$ Million)

Figure 27. Middle East & Africa Circulating Tumor Cell (CTC) Diagnostics Sales Value by Country (%), 2023 VS 2030

Figure 28. Key Countries/Regions Circulating Tumor Cell (CTC) Diagnostics Sales Value (%), (2019-2030)

Figure 29. United States Circulating Tumor Cell (CTC) Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 30. United States Circulating Tumor Cell (CTC) Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 31. United States Circulating Tumor Cell (CTC) Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 32. Europe Circulating Tumor Cell (CTC) Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 33. Europe Circulating Tumor Cell (CTC) Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 34. Europe Circulating Tumor Cell (CTC) Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 35. China Circulating Tumor Cell (CTC) Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 36. China Circulating Tumor Cell (CTC) Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 37. China Circulating Tumor Cell (CTC) Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 38. Japan Circulating Tumor Cell (CTC) Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 39. Japan Circulating Tumor Cell (CTC) Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 40. Japan Circulating Tumor Cell (CTC) Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 41. South Korea Circulating Tumor Cell (CTC) Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 42. South Korea Circulating Tumor Cell (CTC) Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 43. South Korea Circulating Tumor Cell (CTC) Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 44. Southeast Asia Circulating Tumor Cell (CTC) Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 45. Southeast Asia Circulating Tumor Cell (CTC) Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 46. Southeast Asia Circulating Tumor Cell (CTC) Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 47. India Circulating Tumor Cell (CTC) Diagnostics Sales Value, (2019-2030) & (US$ Million)

Figure 48. India Circulating Tumor Cell (CTC) Diagnostics Sales Value by Type (%), 2023 VS 2030

Figure 49. India Circulating Tumor Cell (CTC) Diagnostics Sales Value by Application (%), 2023 VS 2030

Figure 50. Circulating Tumor Cell (CTC) Diagnostics Industrial Chain

Figure 51. Circulating Tumor Cell (CTC) Diagnostics Manufacturing Cost Structure

Figure 52. Channels of Distribution (Direct Sales, and Distribution)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Circulating Tumor Cell CTC Detector Market Research Report 2024

Global CTC Detection Market Research Report 2025

Global Circulating Tumor Cell Diagnostics Market Insights Forecast to 2030

Global Circulating Tumor Cells Market Research Report 2025

Circulating Tumor Cells CTC Liquid Biopsy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Circulating Tumor Cell CTC Detection Market Research Report 2024

Global Circulating Tumor Cells CTCs and Cancer Stem Cells CSCs Market Insights Forecast to 2030

Global Circulating Tumor Cell Detection System Market Research Report 2024

Global Circulating Tumor Cells and Cancer Stem Cells Market Research Report 2024

Circulating Tumor Cell CTC Detection Kit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Circulating Tumor Cell Capture Instrument Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Free Circulating Tumor Cell Detection Market Research Report 2024

Global Liquid Biopsy Products Market Insights Forecast to 2030

Global Circulating Tumor Cell Kit Market Research Report 2024

Global Circulating Tumor DNA Diagnostics Market Research Report 2025

Circulating Tumor Cell Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global ctDNA Detection Kit Market Research Report 2024

Global Cell free Tumor DNA Detection Market Research Report 2025

Global Circulating Tumour DNA ctDNA Testing Market Research Report 2024

RELATED REPORTS

Global Geriatric Care Services Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-17Q6174

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Hospice Software Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-8Z4276

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Geriatric Care Devices Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-8Q8325

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Allied Health Care Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29V19536

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions